Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00006002 | SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 36 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00085527 | FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT00004876 | Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer | completed | Phase 2 | 30 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00006942 | Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00462397 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | unknown | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00561262 | High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 60 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00561314 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 33 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00632047 | Early Detection of Breast Cancer and Cervical Cancer in Women in India | unknown | Phase 2 | 151,538 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00964626 | Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | unknown | Phase 2 | 60 | Russian Academy of Medical SciencesOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00987675 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00988130 | High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer | unknown | Phase 2 | 26 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01100372 | Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | unknown | Phase 2 | 154 | Medical University InnsbruckOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01193855 | Dutasteride in Treating Patients With Prostate Cancer | unknown | Phase 2 | 42 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01229930 | Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 130 | University of GlasgowOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00510653 | Gleevec Study for Patients With Ovarian Cancer | completed | Phase 2 | 73 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00908141 | GM-CSF in Treating Patients With Relapsed Prostate Cancer | completed | Phase 2 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00002538 | Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00685633 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Aug 20, 2013 | clinicaltrials |
| NCT01388621 | Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer(PROVE) | unknown | Phase 2 | 140 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00425334 | Safety Study of Hemospan® in Prostatectomy Patients | completed | Phase 2 | 20 | SangartINDUSTRY | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00003732 | Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer | completed | Phase 2 | 80 | Rigshospitalet, DenmarkOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00075712 | Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 / Phase 3 | 150 | Royal College of Obstetricians and GynecologistsOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00305838 | CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen | unknown | Phase 2 | 200 | Mount Vernon Cancer Centre at Mount Vernon HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00008112 | Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | unknown | Phase 2 | — | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00045461 | Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | unknown | Phase 2 / Phase 3 | 241 | Ludwig-Maximilians - University of MunichOTHER | 3 | Aug 7, 2013 | clinicaltrials |
| NCT00554918 | Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy | completed | Phase 2 | 300 | University Hospital BirminghamOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01100359 | Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer | unknown | Phase 2 | 39 | Medical University InnsbruckOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00014690 | ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 2 | — | AstraZenecaINDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00886717 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 74 | Asan Medical CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01821859 | Abraxane/Bevacizumab | terminated | Phase 2 | 5 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01909388 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy(BRAPROST) | unknown | Phase 2 | 15 | Alfonso Gomez-IturriagaOTHER | 1 | Jul 26, 2013 | clinicaltrials |
| NCT01387841 | Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting | completed | Phase 2 | 120 | Bharath Charitable Cancer Hospital and InstituteOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01901042 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | completed | Phase 2 / Phase 3 | 20 | Federal University of Mato GrossoOTHER | 0 | Jul 17, 2013 | clinicaltrials |
| NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | completed | Phase 2 | 41 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 2 | 7 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00181584 | Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | completed | Phase 2 | 60 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00738140 | Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors | completed | Phase 2 | 15 | Massachusetts General HospitalOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00003517 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00005965 | Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix | completed | Phase 2 | — | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00081172 | Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00748527 | Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | terminated | Phase 2 | 134 | Cancer Research UKOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00006267 | Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer | withdrawn | Phase 2 | 0 | Gynecologic Oncology GroupNETWORK | 0 | Jul 9, 2013 | clinicaltrials |
| NCT00084448 | Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003811 | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | completed | Phase 2 | 27 | Children's Oncology GroupNETWORK | 6 | Jul 4, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00002559 | Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin | completed | Phase 1 / Phase 2 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00485303 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | completed | Phase 2 | 58 | Cougar Biotechnology, Inc.INDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT00002489 | Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Sep 5, 2013source: clinicaltrials